{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02127437","recordId":"NCT02127437","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02127437-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02127437.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02127437.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-04-28","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"78ac31cab0e3a5bd7a9d064399a992207777216cb59f3c2d72f2c43d397ab600","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-02-02","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"6bb006076c815e0e29db5d9f475574b91417bfa56b80bb0a68fe48088e79b9f1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-11-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-11-11","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"f1a220c30f3da113765d6ccf576e72ee83c9b50f1e369f65d8ae1bb64fd90342","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-08-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-08-25","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"c92c4584285d54a7d3d4b323e09a3052a9d92bd5a1126930026ad00d3c00970b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-11-22","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"9a13a6b22f7b0ddee4cf96b99ea0569acf931ba37085eb41dbe03259ca0d7ded","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-12-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-12-20","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"025f60772350ff6c58b7d0f1f93d9f0824a7184df11cf72dcc1c32a3532862c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2019-11-15","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"cdd2fb982bb4c1e6df862d03b70bc45984c9184f26cd5a9e7fcf0664300b5b8b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2026-04-02","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"d3ba73e5cb8c3e6c46b8d690cb541522082c3b1d73797fa5deb6e824a96c3351","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"cc618dd2cbc3a724899bfe9cca534c3979381abf4e25f865e52cd3eded87c02c"}}